Objective: The aim of Present study was undertaken to evaluate the level of prostate -specific antigen (PSA) in patients suffering from carcinoma Prostate along with their Histopathological correlations. Materials and Methods: A total of 250 male patients, of different age groups, presents with various urological complains, attending in medical and surgical OPD were included in the study. All the demographic data were noted. After the diagnosis by PSA, 90 cases were operated and send for histopathological examination in our department. PSA evaluation was done by Chemiluminescens immunoassay (CLIA) methods by fully automated machine supplied by Roche pharma. All data regarding routine tests (CBC, LFT, KFT, TSH, Blood sugar, USG Lower abdomen) were recorded. Result: Out of 250 patients, 36.8% patients were in 61-75 years of age, followed by 34.4% in 51-60 years of age. 33.64% patients had benign prostatic hypertrophy (BPH) followed by 22.40% patients had prostatitis. 19.2% had suspected cases of Ca prostate. 23.06% patients were suffers from Ca prostate with nodal involvement and 1.2% patients had Ca prostate with distant metastasis. In hematological parameter maximum patients (63.6%) were found to have normal haemogram.13.2% patients had anemia. In PSA evaluation, maximum (81.2%) patients were found to have within normal limits of PSA (1-5 ng/mL) followed by 10% had 6-10 ng/mL. 7.2% patients had 11-50 ng/mL and only 1.6% patients had PSA more than 50 ng/mL. Alkaline Phosphatase level was 1-5 IU/L in 82.4% patients followed by [16][17][18][19][20][21][22][23][24][25][26][27][28][29][30][31][32][33][34][35][36][37][38][39][40][41][42][43][44][45] cases and more than 45 IU/L in 1.6% of cases. Median PSA level in histopathologically proved cases of carcinoma prostate was found to 60.5% ng/mL in 4.44% of patients and according to gleason grade PSA level was the 40.9% ng/mL in 8.88% of cases.
Introduction
Prostate-specific antigen (PSA) test measures the level of PSA in our blood. The prostate is a small gland that is part of a man's reproductive system. It is located below the bladder and makes a fluid that is part of semen. PSA is a substance made by the prostate. Men normally have low PSA levels in their blood. A high PSA level may be a sign of prostate cancer, the most common non-skin cancer affecting American men. But high PSA levels can also mean noncancerous prostate conditions, such as infection (prostatitis) or benign prostatic hyperplasia, a noncancerous enlargement of the prostate. Prostate specific antigen (PSA) is a kallikrein like, serine protease. It is a single chain glycoprotein containing 7% carbohydrate by weight. It is produced primarily by epithelial cells of all types of prostatic tissues by normal, as well as malignant cells of the prostate gland. In 1994, the FDA approved the use of PSA test in conjunction with A digital rectal examination (DRE) to test asymptomatic men for prostatic cancer.
Material and Methods
Present study was conducted in the Department of Pathology, Nalanda Medical College, Patna, with the help of Department of Microbiology, Biochemistry and Urology, during the period of June 2015 to May 2017. A total of 250 male patients, of different age groups, presents with various urological complain, attending in medical and surgical OPD were included in the study. All the demographic data were noted. After the diagnosis by PSA, 90 cases was operated and send for histopathological examination in our department. PSA evaluation was done by Chemiluminescens immunoassay (CLIA) methods by fully automated machine supplied by Roche pharma. 
Results

Table-1 Shows Age Distribution of Patients
Conclusion
Our studies show that PSA estimation is approximately 94% sensitive and specific in the diagnosis of Ca Prostate cases. It also shows that PSA has definite prognostic value also. As PSA estimation is easy to perform and non invasive technique, it can be adopted in all district hospital for diagnosis and prognosis of carcinoma prostate.
